Member Info for RuckRover

Bermuda,
If different vaccines worked for different population subsets, could you produce a combined “super vaccine” or would they conflict with each other?

“Now if you feel you can present a NEGATIVE .......... better ....
That actually stands up to scrutiny ...........
Best of luck ....”

No negatives on the science from me.
You are evading the question, why are we trading at a “ludicrously cheap” 5.45p

Chelsea your 10:03..

No it wasn’t Inan who said it was MichaelHighBar. MHB posted loads of negatives along with a more positive “ludicrously cheap” comment. Inan latched onto this and reposted regularly over the next few days. I wanted to see who, on here, thought the share was ludicrously cheap. Personally I don’t, if I did, I would be buying. I think it is cheap compared to its potential.

You have to accept there is a difference between “belittle” and “challenge”. A lot of what Inan says needs to be challenged for the benefit of the less informed. Some of the things he comes out with are just plain wrong. This may be because he expresses his opinion as fact or he gets over enthusiastic. Also, his poor English sometimes conveys an idea he perhaps did not mean.

You are right, I can’t remember us ever having a cross word despite disagreeing on many things. You see where we are now as a buying opportunity as the SP could well jump on good news. I take a contrarian view that it may drop with a placing. We therefore take different actions, no need to fall out about it. If this gets to £1 in the next year your buy and my hold won’t really have much difference will it?

Inan,
Your 10:00 post was absolutely superb - if the question was “how good is Scancell’s approach to developing cancer treatments?”

OK,

Here’s something so provoke the thought process.....

If you think 5p IS ludicrously cheap, how high can it go to still be classed as such, at what level will it move from “ludicrously cheap” to just cheap.

If you think 5p is NOT ludicrously cheap, how low would it need to go to become so?

C7,
It was suggested that the SP was ludicrously cheap. So that’s the topic for discussion, hence in the title. What did you want me to put?

Sorry C7, you mean “why do you think so few are posting?”
I don’t know really, do you?
Possible with such a dearth of news on progress, nothing to say.

Definition of ludicrous
1 : amusing or laughable through obvious absurdity, incongruity, exaggeration, or eccentricity
2 : meriting derisive laughter or scorn as absurdly inept, false, or foolish

So whilst some consider the current SP around the 5p mark “cheap” it doesn’t fit the description of “ludicrous”.

It is cheap compared to Trinity Delta’s (conservative) valuation of 15.6p.

I guess if it was “ludicrously cheap” there would be so many piling in that it wouldn’t stay cheap for long.

Ray,
Big difference between extinct and dormant. Of course if you’ve been dormant too long you will be classed extinct, not there yet IMO.

Ivy,
Thanks for the comprehensive information.
I was diagnosed with acid reflux About 12 years ago. The symptoms were so severe, I was hospitalised with suspected heart attack. I took ppi for many years but read it may not be a good idea to be on them long term. I stopped taking them but had severe acid attacks. I tried again and managed to come off completely about 18 months ago.
I was prescribed naproxen for the sciatica and put on Omeprozole to counteract.
The naproxen didn’t actually stop the pain, neither does coding or paracetamol. I can’t take ibuprofen as it is incompatible with the BP medication.
The only thing I can take that works is annadin extra.

Here you are C7, my earlier comment was directed At everyone EXCEPT LL.

I had managed to wean myself off Omeprazole a year ago but went back on it to counteract the effects of the painkillers for sciatica. Off the painkillers (back on Annadin) so trying to come off the Omeprozole.
I thought it was you who told me it wasn’t a good idea to take Omeprozole long term? I know there are a number of medical conditions where there really is no other choice.

The “ludicrously cheap” comment was directed at everyone that didn’t post - certainly more than one lol!
I’ll bring the thread forward so you can see...

Evening C7, Bunsie,

My wife and I have barely been anywhere since lockdown. We leave the house only for a walk.
We used to eat out every Friday evening at either of two local pubs. I have several conditions that would make Covid worse - age, asthma, male, high BP and being on omeprazole. Since working from home on lock down I have developed sciatica which has got progressively worse over the past 12 weeks so now unable to work at all.

We don’t miss the food eating out, most dishes I can could as well if not better myself. I have also added some new dishes to my repertoire (such as Moussaka which has become a family favourite).
Sunday roasts are a thing of the past as our shopping slot is Sunday evening, too late to cook that day and not enough shelf life for the following week. What doesn’t come we go without. This week it was icing sugar and painkillers- ouch!

The thing we miss about eating out is the social experience. Eating out overseas is even better as often you will get new dishes, impossible to cook at home as you just couldn’t get the ingredients (perhaps in London you could but not in the sticks). Your Naples experience sounds nice Bunsie, made me think of seafood at Jordan’s on Darling harbour. Every bit as good as Doyle’s but without the premium price tag. I like ribeye but the ribeye you get in the US is very different to what we get here. I imagine it’s because it is cut differently?

C7, “are we ludicrously cheap” is a good question. I tried to initiate a debate on it but there we very few takers.

Bunsie, well done on your triumph.

“ i presume you are happy to wait ... for the trial to progress .”
We don’t really have a choice really do we?

Inan,
I was referring to clinical progress of SCIB1 in the treatment of melanoma in reference to LL’s question regarding the announcement of the clinical trial of SCIB1 for the treatment of melanoma “first patient dosed” RNS.
This trial produced some compelling data but finished several years ago, since which time there has been no further patients dosed. We are eagerly awaiting the first patient dosed in the SCIB1 combo trial with Keytruda.
If you could highlight any significant clinical progress with SCIB1 in the treatment of melanoma that I may have overlooked, please let me know.
The point being, I don’t think it is particularly helpful to advertise something that started 10 years ago that has not gone anywhere (yet). One would be forgiven for asking “was it any good?”, “why hasn’t it gone anywhere?
Let’s have some “New” news.

LL,
The SCIB1 melanoma trial and positive results were well publicised at the time.
But that is a long time ago. What we need now is news of further progress which to date has been a long time coming.
Having a platform that hasn’t progressed for years is perhaps not a message you want to broadcast to potential investors.

Bunsie,
The ribeye was great served with chips, mushrooms, tomato and salad. The CDP was perfect with it although I would normally have Bordeaux with steak, maybe a St Emilion.

Best of all, there was plenty of steak left to do crispy Chinese beef on a bed of noodles and mushrooms tonight. A nice bottle of white cotes du Rhône to wash it down.
.

I think the wine has had an effect on my wife. She has just said the Pappo chef du naff was lovely.

No, I’m keeping the generous ones for myself!

Ray,
I’ve got 10 nephews I can lend you a couple.